Evidence map›Paper›PMID 23547051›Full record

ArticleBlood2013

C/EBPα is required for development of dendritic cell progenitors.

Robert S Welner, Deepak Bararia, Giovanni Amabile, Akos Czibere, Touati Benoukraf, Christian Bach, K Disnika Senali Abayratna Wansa, Min Ye, Hong Zhang, Tadafumi Iino and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. C/EBPα activatesScience immunology · 2025
    Article
  5. Article
  6. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Robert S WelnerHarvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Deepak Bararia
Giovanni Amabile
Akos Czibere
Touati Benoukraf
Christian Bach
K Disnika Senali Abayratna Wansa
Min Ye
Hong Zhang
Tadafumi Iino
Christopher J Hetherington
Koichi Akashi
Daniel G Tenen
Harvard University · USHarvard Stem Cell Institute · USKyushu University · JPNational University of Singapore · SGNational University Cancer Institute, Singapore · SG

Funding

TYROSINE KINASE ONCOGENESIS IN MYELOID LEUKEMIAP01CA066996 · NCI · DANA-FARBER CANCER INSTITUTE · PI SCOTT A ARMSTRONG · 1996 to 2026
$52.5M
Hematopoietic stem cell commitmentP01DK080665 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TENEN, DANIEL G · 2008 to 2012
$7.3M
MOLECULAR BIOLOGY OF MYELOID DIFFERENTIATIONR01CA041456 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TENEN, DANIEL G · 1986 to 2010
$4.6M
ROLE OF C/EBPalpha AND MYELOPOIESISR01HL056745 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TENEN, DANIEL G · 1996 to 2010
$3.7M
Molecular biology of myeloid differentiationR01HL112719 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TENEN, DANIEL G · 2012 to 2015
$2.2M
Distinct acute myeloid leukemia subclasses with CEBPA mutationsR01CA118316 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TENEN, DANIEL G · 2007 to 2011
$2.0M
NCI NIH HHS CA118316NCI NIH HHS CA41456NCI NIH HHS CA66996NCI NIH HHS P01 CA066996NCI NIH HHS R01 CA041456NCI NIH HHS R01 CA118316NHLBI NIH HHS HL56745NHLBI NIH HHS R01 HL056745NHLBI NIH HHS R01 HL112719NIDDK NIH HHS DK080665NIDDK NIH HHS P01 DK080665
6 · The paper itself

Abstract

Dendritic cells (DCs) are master regulators of the immune system, but molecular regulation of early DC differentiation has been poorly understood. Here, we report that the transcription factor C/EBPα coordinates the development of progenitor cells required for production of multiple categories of DCs. C/EBPα was needed for differentiation from stem/progenitor cells to common DC progenitors (CDPs), but not for transition of CDP to mature DCs. C/EBPα deletion in mature DCs did not affect their numbers or function, suggesting that this transcription factor is not needed for maintenance of DCs in lymphoid tissues. ChIP-seq and microarrays were used to identify candidate genes regulated by C/EBPα and required for DC formation. Genes previously shown to be critical for DC formation were bound by C/EBPα, and their expression was decreased in the earliest hematopoietic compartments in the absence of C/EBPα. These data indicate that C/EBPα is important for the earliest stages of steady-state DC differentiation.

Indexed as

AnimalsCCAAT-Enhancer-Binding Protein-alphaCell DifferentiationCells, CulturedCluster AnalysisDendritic CellsGene Expression ProfilingGene Knockdown TechniquesLymphoid TissueMiceMice, TransgenicOligonucleotide Array Sequence AnalysisStem CellsCCAAT-Enhancer-Binding Protein-alpha

Identifiers

PMID23547051
PMCPMC3656447
OpenAlexW1969808850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.